XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
12 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
Schedule of effect of the restatement on each financial statement
   As Previously
Reported
   Adjustment    As Restated 
Consolidated Balance Sheet as of December 31, 2020            
Warrant liabilities  $
   $143,295   $143,295 
Total liabilities   14,822    143,295    158,117 
Additional paid-in capital   425,364    (108,280)   317,084 
Accumulated deficit   (93,186)   (35,015)   (128,201)
Total stockholders’ equity   332,191    (143,295)   188,896 
                
                
Consolidated Statement of Operations for the Year Ended December 31, 2020               
Change in fair value of warrant liabilities  $
   $35,015   $35,015 
Net loss   (25,591)   (35,015)   (60,606)
Basic and diluted weighted average shares outstanding   (0.30)   (0.42)   (0.72)
                
                
Consolidated Statement of Cash Flows for Year Ended December 31, 2020               
Cash Flows from Operating Activities:               
Net loss  $(25,591)  $(35,015)  $(60,606)
Adjustments to reconcile net loss to net cash used in operating activities:               
Change in fair value of warrant liabilities   
    35,015    35,015 
Non-Cash Investing and Financing Activities:               
Initial measurement of warrants assumed in connection with the Business Combination accounted for as liabilities   
    108,280    108,280